AU2006309286A1 - Production of multivalent virus like particles - Google Patents
Production of multivalent virus like particles Download PDFInfo
- Publication number
- AU2006309286A1 AU2006309286A1 AU2006309286A AU2006309286A AU2006309286A1 AU 2006309286 A1 AU2006309286 A1 AU 2006309286A1 AU 2006309286 A AU2006309286 A AU 2006309286A AU 2006309286 A AU2006309286 A AU 2006309286A AU 2006309286 A1 AU2006309286 A1 AU 2006309286A1
- Authority
- AU
- Australia
- Prior art keywords
- peptide
- virus
- viral
- capsid fusion
- fusion peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/14011—Bromoviridae
- C12N2770/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/14011—Bromoviridae
- C12N2770/14023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68654105P | 2005-06-01 | 2005-06-01 | |
| US60/686,541 | 2005-06-01 | ||
| PCT/US2006/021262 WO2007053188A2 (en) | 2005-06-01 | 2006-06-01 | Production of multivalent virus like particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2006309286A1 true AU2006309286A1 (en) | 2007-05-10 |
Family
ID=38006346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006309286A Abandoned AU2006309286A1 (en) | 2005-06-01 | 2006-06-01 | Production of multivalent virus like particles |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070041999A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1885394A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009501001A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080018176A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101287489A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006309286A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0611336A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2608515A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007053188A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100021391A1 (en) * | 2006-07-14 | 2010-01-28 | Montana State University | Novel nanoparticles for biofilm targeting |
| EP2601969B1 (en) | 2006-09-29 | 2016-03-30 | Takeda Vaccines, Inc. | Norovirus vaccine formulations |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| CN104740624B (zh) | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| US9566323B2 (en) * | 2009-06-19 | 2017-02-14 | Eyegene Inc. | Vaccine for cervical cancer |
| CA2804501C (en) | 2010-07-06 | 2021-01-26 | Novartis Ag | Noro virus derived immunogenic compositions and methods |
| PH12014500093A1 (en) | 2011-07-11 | 2014-03-17 | Takeda Vaccines Inc | Parenteral norovirus vaccine formulations |
| PL3597757T3 (pl) * | 2012-05-11 | 2021-05-31 | Medicago Inc. | Wytwarzanie cząstek podobnych do rotawirusów w roślinach |
| US10086062B2 (en) | 2012-07-05 | 2018-10-02 | Ohio State Innovation Foundation | Infectious pancreatic necrosis virus (IPNV) vaccine compositions |
| WO2014008475A2 (en) | 2012-07-05 | 2014-01-09 | The Ohio State University | Compositions and methods related to viral vaccines |
| EP3089755A1 (en) * | 2014-01-03 | 2016-11-09 | Fundacion Biofisica Bizkaia | VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF |
| WO2015191546A2 (en) * | 2014-06-10 | 2015-12-17 | The Board Of Regents Of The University Of Texas System | Adp-ribose detection reagents |
| CN105018463A (zh) * | 2015-06-05 | 2015-11-04 | 北京百迈客生物科技有限公司 | 一种用于次生代谢物含量高的植物组织的dna提取方法 |
| KR101830792B1 (ko) * | 2016-01-27 | 2018-02-21 | 건국대학교 산학협력단 | 항균 펩타이드를 포함하는 불용성 융합단백질 및 이를 이용한 항균 펩타이드의 제조 방법 |
| CN108558990A (zh) * | 2018-01-05 | 2018-09-21 | 山东省科学院生态研究所 | 肿瘤靶向肽f3修饰的豇豆褪绿斑驳病毒样颗粒的构建、表达及其应用 |
| US20230038487A1 (en) * | 2019-11-25 | 2023-02-09 | The Regents Of The University Of California | Modified viral therapeutics and uses thereof |
| US20250108108A1 (en) * | 2020-04-14 | 2025-04-03 | The Regents Of The University Of California | Hybrid flu-coronavirus vaccine |
| CN117098553A (zh) | 2020-11-11 | 2023-11-21 | 加州理工学院 | 多价载体和相关疫苗组合物 |
| CN115747170B (zh) * | 2022-08-29 | 2023-08-04 | 四川大学 | 一种豇豆褪绿斑驳病毒-多肽复合物及其在骨质疏松治疗中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
| GB9414118D0 (en) * | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
| US6042832A (en) | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| AU742409B2 (en) * | 1997-09-05 | 2002-01-03 | Medimmune, Llc | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| US6171591B1 (en) * | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
| KR100312456B1 (ko) * | 1999-03-13 | 2001-11-03 | 윤덕용 | 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자 |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| US7135282B1 (en) * | 1999-10-14 | 2006-11-14 | The Dow Chemical Company | Viral particles with exogenous internal epitopes |
| GB9924352D0 (en) * | 1999-10-14 | 1999-12-15 | Hellendoorn Koen | Methods,compositions and applications relating to the generation of novel plant viral particles |
| US6552006B2 (en) * | 2000-01-31 | 2003-04-22 | The Regents Of The University Of California | Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| US20030050268A1 (en) * | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
| WO2003068804A2 (en) * | 2002-02-14 | 2003-08-21 | Novavax, Inc. | Novel insect cell line |
| WO2003087129A2 (en) * | 2002-04-08 | 2003-10-23 | Siga Technologies, Inc. | Immunogenic peptides, and method of identifying same |
| JP2006507800A (ja) * | 2002-06-07 | 2006-03-09 | ラージ・スケール・バイオロジー・コーポレイション | 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム |
| MXPA05000287A (es) * | 2002-07-05 | 2005-09-08 | Leclerc Denis | Particula viral adyuvante. |
| WO2005005614A2 (en) | 2003-07-03 | 2005-01-20 | Pecos Labs, Inc. | Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| AU2004255470B2 (en) * | 2003-07-10 | 2010-08-19 | Cytos Biotechnology Ag | Packaged virus-like particles |
| CA2547511A1 (en) * | 2003-12-01 | 2005-07-28 | Dow Global Technolgies Inc. | Recombinant icosahedral virus like particle production in pseudomonads |
-
2006
- 2006-06-01 CA CA002608515A patent/CA2608515A1/en not_active Abandoned
- 2006-06-01 JP JP2008514849A patent/JP2009501001A/ja active Pending
- 2006-06-01 EP EP06844120A patent/EP1885394A4/en not_active Withdrawn
- 2006-06-01 WO PCT/US2006/021262 patent/WO2007053188A2/en not_active Ceased
- 2006-06-01 BR BRPI0611336-2A patent/BRPI0611336A2/pt not_active IP Right Cessation
- 2006-06-01 CN CNA2006800196237A patent/CN101287489A/zh active Pending
- 2006-06-01 AU AU2006309286A patent/AU2006309286A1/en not_active Abandoned
- 2006-06-01 US US11/444,827 patent/US20070041999A1/en not_active Abandoned
- 2006-06-01 KR KR1020077028015A patent/KR20080018176A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007053188A3 (en) | 2007-12-06 |
| BRPI0611336A2 (pt) | 2010-08-31 |
| EP1885394A2 (en) | 2008-02-13 |
| EP1885394A4 (en) | 2009-10-21 |
| KR20080018176A (ko) | 2008-02-27 |
| JP2009501001A (ja) | 2009-01-15 |
| WO2007053188A2 (en) | 2007-05-10 |
| US20070041999A1 (en) | 2007-02-22 |
| CA2608515A1 (en) | 2007-05-10 |
| CN101287489A (zh) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070041999A1 (en) | Production of multivalent virus like particles | |
| Naskalska et al. | Virus like particles as immunogens and universal nanocarriers | |
| Peacey et al. | Versatile RHDV virus‐like particles: Incorporation of antigens by genetic modification and chemical conjugation | |
| AU2004313458B2 (en) | Recombinant icosahedral virus like particle production in pseudomonads | |
| AU784425B2 (en) | Modified plant viruses and methods of use thereof | |
| US20130236491A1 (en) | Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes | |
| CN104271594B (zh) | 用于初免‑加强疫苗的水疱性口炎病毒 | |
| JP2009502789A (ja) | 組み換えインフルエンザワクチン | |
| US20050260758A1 (en) | High efficiency peptide production in plant cells | |
| US20070128213A1 (en) | Novel plant virus particles and methods of inactivation thereof | |
| US20090093019A1 (en) | Production and in vivo assembly of soluble recombinant icosahedral virus-like particles | |
| Ogrina et al. | Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens | |
| Walker et al. | Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins | |
| US20070207167A1 (en) | Immunologically enhanced recombinant vaccines | |
| CN106459157A (zh) | 基于乙型肝炎核心抗原的疫苗 | |
| Manuel-Cabrera et al. | Immune response to a potyvirus with exposed amino groups available for chemical conjugation | |
| CZ20021303A3 (cs) | Virové částice s exogenními epitopy uvnitř částice | |
| CN107624117A (zh) | 基于乙型肝炎核心抗原的疫苗 | |
| KR20060091713A (ko) | 파보바이러스 항원의 세포표면 발현벡터 및 상기 벡터에의해 형질전환된 미생물 | |
| WO2025260018A1 (en) | Particle delivery for self-amplifying vaccines | |
| US20140010836A1 (en) | Antigenic gly1 polypeptides | |
| JP2012139193A (ja) | 融合タンパク質 | |
| TW202311281A (zh) | 一種自組裝蛋白質奈米粒子及其應用 | |
| LV15007B (lv) | Kartupeļu vīrusam PVM līdzīgo daļiņu iegūšana | |
| LV15006B (lv) | Daudzziedu airenes raibuma vīrusam līdzīgo daļiņu iegūšana |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |